Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines

Journal of Urology

Volumn 163, Issue 3, 2000, Pages 1027-1032

  Guo, Chuanhai ^a   Luttrell, Louis M ^a   Price, David T ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

ERK; Mitogen activated protein kinase; Prostate cancer; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANDROSTANOLONE; EPIDERMAL GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL; CELL PROLIFERATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOBLOTTING; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

EID: 0033951081     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67876-7     Document Type: Article

References (37)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A. Cancer Statistics.: CA Cancer J Clin, 48: 6, 1998
2. Steiner, M. S.: Role of peptide growth factors in the prostate: a review. Urology, 42: 99, 1993
3. Ware, J. L.: Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev, 12: 287, 1993
4. Russell, P. J., Bennett, S. and Stricker, P.: Growth factor involvement in progression of prostate cancer. Clin Chem, 44: 705, 1998
5. Eaton, C. L., Harper, D. M., Rushmere, F. N. and Griffiths, K.: Steroids and the prostate. J Steroid Biochem Molec Bio., 40: 175, 1991
6. Kokontis, J. M. and Liao, S.: Molecular action of androgen in the normal and neoplastic prostate. Vitamins Hormones, 55: 219, 1999
7. Galbraith, S. M. and Duchesne, G. M.: Androgens and prostate cancer: biology, pathology and hormonal therapy. Eur J Cancer, 33: 545, 1997
8. Sherwood, E. R. and Lee, C.: Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J Urol, 13: 290, 1995
9. Howe, L. R. and Marshall, C. J.: Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1. J Biol Chem, 268: 20717, 1993
10. Daub, K., Wallasch, C., Lankenau, A., Herrlich, A. and Ullrich, A.: Signal characteristics of G protein-transactivated EGF receptor. EMBO J, 16: 7032, 1997
11. Griffiths, K., Morton, M. S. and Nicholson, R. I.: Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer. Eur Urol, 32(suppl 3): 24, 1997
12. Dorkin, T. J. and Neal, D. E.: Basic science aspects of prostate cancer. Semin Cancer Biol, 8: 21, 1997
13. Zhu, X. and Liu, J-P.: Steroid-independent activation of androgen receptor in androgen-independent prostate cancer: A possible role for the MAP kinase signal transduction pathway. Mol Cell Endocrinol, 134: 9, 1997
14. Cato, A. C. B. and Peterziel, H.: The androgen receptor as mediator of gene expression and signal transduction pathways. Trends Endocrinol Metabol, 9: 150, 1998
15. Singh, M., Setalo, G. Jr., Guan, X., Warren, M. and Toran-Allerand, C. D.: Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci, 19: 1179, 1999
16. Krstic, M. D., Rogatsky, I., Yamamoto, K. R. and Garabedian, M. J.: Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol, 17: 3947, 1997
17. β expressed in Chinese hamster ovary cells. Mol Endocrinol, 13: 307, 1999
18. Cobb, M. H., Helper, J. E., Cheng, M. and Robbins, D. J.: The mitogen-activated protein kinases, ERK1 and ERK2. Semin Cancer Biol, 5: 261, 1994
19. Neary, J. T.: MAPK cascades in cell growth and death. News Physiol Sci, 12: 286, 1997
20. Bornfeldt, K. E., Campbell, J. S., Koyama, H., Argast, G. M., Leslie, C. C., Raines, E. W., Krebs, E. G. and Ross, R.: The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. J Clin Invest, 100: 875, 1997
21. Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R. and Mercola, D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J Biol Chem, 272: 14041, 1997
22. Bost, F., McKay, R., Dean, N. and Mercola, D. The JUN kinase/ stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J Biol Chem, 272: 33422, 1997
23. Sivaraman, V., Wang, H., Nuovo, G. and Malbon, C.: Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest, 99: 1478, 1997
24. Coutts, A. S. and Leigh, M. C.: Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res, 58: 4071, 1998
25. Magi-Galluzzi, C., Montironi, R., Cangi, M. G., Wishnow, K. and Loda, M.: Mitogen-activated protein kinases and apoptosis in PIN. Virchows Arch, 432: 407, 1998
26. Putz, T., Culig, Z., Eder, I. E., Nessler-Menardi, C., Bartsch, G., Grunicke, H., Uberall, F. and Klocker, H.: Epidermal growth factor (EGR) receptor blockade inhibits the action of EGF, Insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Res, 59: 227, 1999
27. Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. F. and Weber, M. J.: Activation of Mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res, 59: 279, 1999
28. Price, D. T., Della Rocca, G., Guo, C., Ballo, M. S., Schwinn, D. A. and Luttrell, L. M.: Increased activation of extracellular signal-regulated kinase in human prostate cancer. J Urol, 162: 1537, 1999
29. Alessi, D. R., Cuenda, A., Chent, P., Dudley, D. T. and Saltiel, A. R.: PD098059 is a specific inhibitor of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem, 270: 27489, 1995
30. Eguchi, S., Numaguchi, K., Iwasaki, H., Matsumoto, T., Yamakawa, T., Utsunomiya, H., Motley, E. D., Kawakatsu, H., Owada, K. M., Hirata, Y., Marumo, F. and Inagami, T.: Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem, 273: 8890, 1998
31. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, R. A. and Murphy, G. P.: LNCaP model of human prostatic carcinoma. Cancer Res, 43: 1809, 1983
32. Kaighn, M. E., Narayan, S., Ohnuki, Y., Lechner, J. F. and Jones, L. W.: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol, 17: 16, 1979
33. Ullrich, A. and Schlessinger, J.: Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203, 1990
34. Fantl, W. J., Johnson, D. E. and Williams, L. T.: Signaling by receptor tyrosine kinases. Ann Rev Biochem, 62: 453, 1993
35. Sherwood, E. R., Van Dongen, J. L., Wood, C. G., Liao, S., Kozlowski, J. M. and Lee, C.: Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Br J Cancer, 77: 855, 1998
36. Gil-Diez de Medina, S., Salomon, L., Colombel, M., Abbou, C. C., Bellot, J., Thiery, J. P., Radvanyi, F., Van der Kwast, T. H. and Chopin, D. K.: Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer. Hum Pathol, 29: 1005, 1998
37. Scher, H. I., Sarkis, I., Reuter, V., Cohen, D., Netto, G., Petrylak, D., Lianes, P., Fuks, Z., Mendelshn, J. and Cordon-Cardo, C.: Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms. Clin Cancer Res, 1: 545, 1995